What are the signs and symptoms of male genital Human Papillomavirus (HPV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs of Male Genital HPV Infection

Most HPV infections in men are completely asymptomatic and have no visible signs or symptoms. 1, 2

Clinical Manifestations When Present

Genital Warts (Most Common Visible Sign)

  • Visible genital warts are the most common clinical manifestation of HPV infection in men, caused by HPV types 6 and 11 in over 90% of cases 1, 3
  • Appear as small, cauliflower-like growths on the penis, scrotum, perineum, and perianal skin 1, 2
  • Can occur on the urethra, anus, and mouth, though less commonly 1
  • May be painful, friable (easily bleeding), or pruritic (itchy), though commonly asymptomatic 1
  • Highly infectious—approximately 65% of sexual partners of infected individuals will develop warts themselves 3

Location-Specific Presentations

  • External genital areas: Penis, vulva, scrotum, perineum, and perianal skin are most commonly affected 1
  • Intra-anal warts: Seen predominantly in men who have had receptive anal intercourse, distinct from perianal warts which can occur without anal sex history 1
  • Urethral meatus: Warts can develop at the urethral opening 1
  • Oral cavity: Less common but possible with HPV types 6 and 11 1

High-Risk HPV Types (Usually Invisible)

Oncogenic HPV Manifestations

  • HPV types 16,18,31,33, and 35 rarely cause visible warts but are associated with penile, anal, and oral cancers 1
  • May present as penile intraepithelial neoplasia: squamous cell carcinoma in situ, bowenoid papulosis, Erythroplasia of Queyrat, or Bowen's disease 1
  • Approximately 40% of invasive penile carcinomas are attributable to HPV 4
  • Lesions that are pigmented, indurated, fixed, and ulcerated warrant biopsy to rule out malignancy 1

Critical Diagnostic Limitations

No Validated Screening Test

  • No clinically validated test exists for men to determine if they have HPV infection 1
  • There is currently no FDA-approved test for HPV detection in men 5
  • Diagnosis of genital warts is typically clinical, based on visual inspection 1
  • Biopsy is only needed when: diagnosis is uncertain, lesions don't respond to standard therapy, disease worsens during therapy, patient is immunocompromised, or warts are pigmented/indurated/fixed/ulcerated 1

Natural History and Prevalence

Infection Patterns

  • Genital HPV infection is very common in men, with prevalence estimated at 65.2% in asymptomatic males aged 18-70 years 3
  • Most sexually active adults will get HPV at some point in their lives, though most will never know it 1
  • Most HPV infections in men clear within one year—median time to clearance is 5.9 months, with 75% clearing within 12 months 5, 3
  • HPV infections may be less likely to persist in men than in women 3

Important Clinical Pitfalls

Common Misconceptions

  • The absence of visible signs does not mean absence of infection—most infections are subclinical 1, 5
  • HPV can be transmitted even when no visible signs or symptoms are present 2, 5
  • Different HPV types have different clinical significance: types causing genital warts (6,11) differ from those causing cancers (16,18,31,33,35) 1, 5
  • A diagnosis of HPV in one partner is not indicative of sexual infidelity, as infection could have been acquired years earlier 1, 5
  • HPV infection may persist in a dormant state and become infectious intermittently throughout a patient's lifetime 5

Risk Factors for Visible Disease

  • Lifetime number of sexual partners is the most significant risk factor for HPV acquisition 3
  • Lack of neonatal circumcision and phimosis are strongly associated with penile cancer risk 4
  • Immunosuppression increases risk of persistent infection and clinical manifestations 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Key Differences Between HPV and HSV

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

HPV Positive Status in Men: Natural Resolution and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.